FinziApp

The therapy-accompanying FINZI app to support the treatment of stage III non-small cell lung cancer offers many helpful functions and provides further information about the disease and therapy. To find out whether the FINZI app is suitable for you, speak to your doctor.

FINZI supports patients during lung cancer therapy with many functions:
• Information about the disease, diagnosis, treatment options and much more. m.
• A therapy diary for documenting symptoms
• A calendar that reminds you of the many appointments
• Checklists so that the next appointment is structured
• A glossary that explains the many new terms
• Further addresses and contact points for patients

All data collected is only stored on your device; the publishers of FinziApp have no access to your data.

Information in accordance with Section 5 Paragraph 1 of the E-Commerce Act and disclosure in accordance with Section 25 of the Media Act
Service providers and media owners
AstraZeneca Austria GmbH
Right Wienzeile 223
1120 Vienna
Tel.: +43 1 711 310
Fax: +43 1 711 31-221
Email: info.at@astrazeneca.com
Commercial register number: FN 51184 x Vienna Commercial Court
UID number: ATU36743404

Managing Director
Dr. Michael Pohl
shareholder
AstraZeneca Continent B.V.